Discovery Laboratories (DSCO)
Discovery Laboratories Market Cap: 110.87M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
DSCO Market Cap Rankings
| Overall | 24th percentile | 3518 of 4649 |
| Sector | 32nd percentile | 356 of 525 in Healthcare |
| Industry | 34th percentile | 108 of 164 in Biotechnology |
DSCO Market Cap Range, Past 5 Years
| Minimum | 4.961M | Dec 2010 |
| Maximum | 238.23M | Jun 2007 |
| Average | 114.48M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these DSCO related companies
DSCO News
RT @pjeffry000 $ARNA is this another $DSCO? Not quite, $DSCO was FDA approved when it pulled back. $ARNA still has to get there.
about 13 days ago by Glopolon
about 13 days ago by Glopolon
$MNST $BKS even $DSCO. All signs that "spikes" are the new norm and the buy & hold is shifting to trading the news.
about 28 days ago by BigKarma
about 28 days ago by BigKarma
$DSCO moving nice. volume will make this pop in from 2.67. easy gap up to next resistance 3.40. target 3.71 next target 4.30
about 29 days ago by newyorkisheaven
about 29 days ago by newyorkisheaven
$DSCO now back into the Gap New Hod 3.10 avter testing the 50 SMA. http://stks.co/3a3O
about 29 days ago by GoofyGolfa
about 29 days ago by GoofyGolfa
$VVUS I'm not seeing the Avanafil reaction as unusual. $DSCO and $AFFY sold off too upon approval. Qnexa is what will make it pop.
about 31 days ago by abubnic
about 31 days ago by abubnic
$DSCO Adding here at 3.06 for a D/T. Adding more anything closer to 3
about 32 days ago by ThirstyApples
about 32 days ago by ThirstyApples
Discovery Labs to Report First Quarter 2012 Results and Hold Conference Call on Thursday, May 3, 2012
Apr 26, 4:15PM GlobeNewswire
Apr 26, 4:15PM GlobeNewswire
Discovery Labs Reports Fourth Quarter Financial Results and Highlights Recent Milestones
Mar 29, 7:15AM PR Newswire
Mar 29, 7:15AM PR Newswire
Discovery Labs to Report Fourth Quarter 2011 Results and Hold Conference Call on Thursday, March 29, 2012
Mar 26, 11:00AM GlobeNewswire
Mar 26, 11:00AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DSCO | 2.56 | -0.04 | -1.54% | 110.87M |
| DRYS | 2.29 | +0.04 | +1.78% | 937.50M |
| DPS | 41.09 | +0.33 | +0.81% | 8.714B |
| DPM | 42.04 | -0.34 | -0.80% | 2.117B |
| DOX | 29.17 | -0.01 | -0.03% | 4.992B |
| DOW | 31.30 | -0.25 | -0.79% | 37.10B |
| EVOL | 7.07 | +0.13 | +1.87% | 78.48M |
| EVO | 15.10 | +0.09 | +0.59% | |
| EVN | 13.80 | +0.02 | +0.15% | |
| EVK | 1.73 | +0.00 | +0.00% | 25.53M |
